{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-23-000031","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.809526+00:00","generated_at":"2026-06-15T23:51:39.554756+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Labcorp promotes Mark Schroeder to President Diagnostics & COO; salary $650K plus equity","bullets":["Mark Schroeder appointed EVP, President Diagnostics & COO effective May 1, 2023, as part of planned spin-off of Clinical Development business.","Previously served as EVP, President Diagnostics Laboratory Operations and Global Supply Chain.","Base salary increased to $650,000; receives RSU and PSU awards each valued at $100,000 and stock option award valued at $300,000.","Equity awards granted on May 5, 2023; spin-off previously announced."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-23-000031","json":"https://secwatch.observer/filing/0000920148-23-000031.json","markdown":"https://secwatch.observer/filing/0000920148-23-000031.md","text":"https://secwatch.observer/filing/0000920148-23-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000031/0000920148-23-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000031/lh-20230501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:51:39.554756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1fbb670527","claim":"Mark S. Schroeder was appointed as Executive Vice President, President Diagnostics & Chief Operations Officer at LABCORP HOLDINGS INC..","evidence_excerpt":"Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000031/0000920148-23-000031-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, President Diagnostics & Chief Operations Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}